tiprankstipranks
Cytosorbents Corp (CTSO)
NASDAQ:CTSO
US Market

Cytosorbents (CTSO) Income Statement

Compare
473 Followers

Cytosorbents Income Statement

Last quarter (Q3 2024), Cytosorbents's total revenue was $8.61B, an increase of 110975.51% from the same quarter last year. In Q3, Cytosorbents's net income was $-2.33B. See Cytosorbents’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 36.35M$ 29.36M$ 40.11M$ 39.45M$ 22.77M
Gross Profit
$ 22.39M$ 15.40M$ 29.06M$ 28.40M$ 15.40M
Operating Expenses
$ 53.60M$ 46.93M$ 51.81M$ 38.77M$ 34.38M
Depreciation and Amortization
$ 2.03M$ 1.13M$ 1.13M$ 660.79K$ 581.53K
EBITDA
$ -29.18M$ -30.00M$ -22.01M$ -9.71M$ -18.74M
Operating Income
$ -31.21M$ -31.52M$ -22.75M$ -10.37M$ -18.97M
Other Income/Expenses
$ 1.89M$ -2.38M$ -2.55M$ 1.41M$ -1.38M
Pretax Income
$ -29.32M$ -33.91M$ -25.30M$ -8.96M$ -20.36M
Net Income
$ -28.51M$ -32.81M$ -24.56M$ -7.84M$ -19.27M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.64$ -0.75$ -0.57$ -0.20$ -0.60
Diluted EPS
$ -0.64$ -0.75$ -0.57$ -0.20$ -0.60
Weighted Average Shares Outstanding
44.66M 43.57M 43.36M 38.82M 32.26M
Weighted Average Shares Outstanding (Diluted)
44.66M 43.57M 43.36M 38.82M 32.26M
Currency in USD

Cytosorbents Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis